aluminum sulfate has been researched along with Toxoplasmosis in 4 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (25.00) | 24.3611 |
2020's | 3 (75.00) | 2.80 |
Authors | Studies |
---|---|
Deng, JH; Deng, PM; Fu, Y; Huang, J; Qi, M; Shi, TY; Sun, HC; Xie, RH | 1 |
Abou-El-Naga, IF; Hassan, EME; Meselhey, RA; Sabry, D; Tawfeek, GM; Younis, SS | 1 |
Ahmadpour, E; Alizadeh, P; Daryani, A; Hassannia, H; Kazemi, T; Pagheh, AS; Pereira, ML; Rezaei, F; Rodrigues Oliveira, SM | 1 |
Cong, H; Guo, J; Han, Y; Hao, Z; He, S; Lv, G; Song, P; Zhou, A; Zhou, H; Zhou, J | 1 |
4 other study(ies) available for aluminum sulfate and Toxoplasmosis
Article | Year |
---|---|
Protective efficacy of
Topics: Animals; Antibodies, Protozoan; Antigens, Protozoan; Humans; Lactic Acid; Mice; Mice, Inbred BALB C; Nanoparticles; Protozoan Proteins; Protozoan Vaccines; Recombinant Proteins; Toxoplasma; Toxoplasmosis | 2023 |
Protective efficacy of Toxoplasma gondii infected cells-derived exosomes against chronic murine toxoplasmosis.
Topics: Animals; Antibodies, Protozoan; Antigens, Protozoan; CD8-Positive T-Lymphocytes; Exosomes; Humans; Mice; Protozoan Proteins; Protozoan Vaccines; Toxoplasma; Toxoplasmosis; Toxoplasmosis, Animal | 2023 |
Protective effect of a DNA vaccine cocktail encoding ROP13 and GRA14 with Alum nano-adjuvant against Toxoplasma gondii infection in mice.
Topics: Adjuvants, Immunologic; Alum Compounds; Animals; Lymphocyte Activation; Mice; Mice, Inbred BALB C; Protozoan Proteins; Toxoplasma; Toxoplasmosis; Vaccines, DNA | 2021 |
Vaccination with toxofilin DNA in combination with an alum-monophosphoryl lipid A mixed adjuvant induces significant protective immunity against Toxoplasma gondii.
Topics: Actin Capping Proteins; Adjuvants, Immunologic; Alum Compounds; Animals; Antibody Formation; Female; Immunity, Cellular; Lipid A; Mice, Inbred BALB C; Protozoan Proteins; Protozoan Vaccines; Toxoplasma; Toxoplasmosis; Vaccines, DNA | 2017 |